The expanding role of somatostatin analogues in the treatment of neuroendocrine tumours: the CLARINET study

被引：9

作者：

Kaltsas, Gregory ^{[1
]}

Grossman, Ashley B. ^{[2
]}

机构：

[1] Natl Tech Univ Athens, Dept Pathophysiol, Athens 11527, Greece

[2] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England

来源：

CLINICAL ENDOCRINOLOGY | 2015年 / 83卷 / 06期

关键词：

PROGNOSTIC-FACTORS; RECEPTOR BIOLOGY; EXPRESSION; SCINTIGRAPHY; MANAGEMENT; EVEROLIMUS; UPDATE;

D O I：

10.1111/cen.12831

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：759 / 761

页数：3

共 19 条

[1] Indium-111-pentetreotide scintigraphy and somatostatin receptor subtype 2 expression: New prognostic factors for malignant well-differentiated endocrine tumors [J].

Asnacios, Amani ;

Courbon, Frederic ;

Rochaix, Philippe ;

Bauvin, Eric ;

Cances-Lauwers, Valerie ;

Susini, Christiane ;

Schulz, Stefan ;

Boneu, Andree ;

Guimbaud, Rosine ;

Buscail, Louis .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (06) :963-970

[2] Somatostatin receptor biology in neuroendocrine and pituitary tumours: part 2-clinical implications [J].

Cakir, Mehtap ;

Dworakowska, Dorota ;

Grossman, Ashley .

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2010, 14 (11) :2585-2591

[3] Somatostatin receptor biology in neuroendocrine and pituitary tumours: part 1-molecular pathways [J].

Cakir, Mehtap ;

Dworakowska, Dorota ;

Grossman, Ashley .

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2010, 14 (11) :2570-2584

[4]

Caplin ME, 2014, NEW ENGL J MED, V371, P1556, DOI [10.1056/NEJMc1409757, 10.1056/NEJMoa1316158]

[5] Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanisms [J].

Grozinsky-Glasberg, Simona ;

Shimon, Ilan ;

Korbonits, Marta ;

Grossman, Ashley B. .

[6] The diagnosis and medical management of advanced neuroendocrine tumors [J].

Kaltsas, GA ;

Besser, GM ;

Grossman, AB .

ENDOCRINE REVIEWS, 2004, 25 (03) :458-511

[7] Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas [J].

Kouvaraki, MA ;

Ajani, JA ;

Hoff, P ;

Wolff, R ;

Evans, DB ;

Lozano, R ;

Yao, JG .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (23) :4762-4771

[8] Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors [J].

Kwekkeboom, Dik J. ;

Kam, Boen L. ;

van Essen, Martijn ;

Teunissen, Jaap J. M. ;

van Eijck, Casper H. J. ;

Valkema, Roelf ;

de Jong, Marion ;

de Herder, Wouter W. ;

Krenning, Eric P. .

[9] THE CLINICAL USE OF SOMATOSTATIN ANALOGS IN THE TREATMENT OF CANCER [J].

LAMBERTS, SWJ ;

KRENNING, EP ;

KLIJN, JGM ;

REUBI, JC .

BAILLIERES CLINICAL ENDOCRINOLOGY AND METABOLISM, 1990, 4 (01) :29-49

[10] Guidelines for Acromegaly Management: An Update [J].

Melmed, S. ;

Colao, A. ;

Barkan, A. ;

Molitch, M. ;

Grossman, A. B. ;

Kleinberg, D. ;

Clemmons, D. ;

Chanson, P. ;

Laws, E. ;

Schlechte, J. ;

Vance, M. L. ;

Ho, K. ;

Giustina, A. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (05) :1509-1517

← 1 2 →